FDA Approves Use of Menactra® Vaccine for Booster Immunization Against Potentially Deadly Disease

Approval aligns with Centers for Disease Control and Prevention’s recommendations for meningococcal vaccination September 11, 2014 Sanofi Pasteur, the vaccines division of Sanofi , announced today that the U.S. Food and Drug Administration (FDA) approved use of Menactra® [Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine] for booster vaccination against meningococcal disease in persons 15 years …